Asia-Pacific Americas Africa Europe Middle East

PHAPROS TBK PT

Company Profile:

PT Phapros Tbk Company Introduction:

PT Phapros Tbk is a prominent Indonesian pharmaceutical company. Established in 1954, it has grown to become one of the leading players in the country's pharmaceutical industry. The company is engaged in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription drugs, over-the-counter (OTC) medications, and health products. Phapros is known for its commitment to quality and innovation, adhering to international manufacturing standards. It is a publicly listed company on the Indonesia Stock Exchange (IDX) and is part of the Bio Farma Group, a state-owned enterprise.

It is a factory.

Enterprise Products

PT Phapros Tbk, an Indonesian pharmaceutical company, manufactures and sells a wide range of pharmaceutical products. These include:

Antimo (for motion sickness)

Becefort (multivitamin)

Livron B Plex (multivitamin)

Paracetamol (analgesic and antipyretic)

Ibuprofen (anti-inflammatory and analgesic)

Dexamethasone (corticosteroid)

Amoxicillin (antibiotic)

Cefadroxil (antibiotic)

Omeprazole (proton pump inhibitor for gastric issues)

Metformin (antidiabetic)

Salbutamol (bronchodilator for respiratory conditions)

Simvastatin (for cholesterol management)

Amlodipine (for hypertension)

Diazepam (anxiolytic and muscle relaxant)

Various cough and cold remedies

Dermatological creams and ointments

Other generic and branded pharmaceutical products across various therapeutic classes such as cardiovascular, central nervous system, musculoskeletal, urogenital, and anti-infectives.

Business Registration Information:

Manager:

Hadi Kardoko (President Director), Zahra Adila (Corporate Secretary)

Phone:

+62 24 7605992, +62 24 7605993

E-mail:

investor@phapros.co.id, corsec@phapros.co.id

Official Website:
Address:

Jalan Simongan Raya No. 125, Semarang 50149, Indonesia

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.